Sign-up to Receive
Our Latest Insights

CURE
VanEck Genomics and Healthcare Innovators UCITS ETF

Growth of hypothetical $100 investment as of 27 Jan 2023

3 Months|
TO

Performance History* (%)

  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVFHCTR (Index) -4.19 8.94 -24.99 -24.99 -- -- -- 4.11
  1 MO* 3 MO* YTD* 1 YR 3 YR 5 YR 10 YR ETF INCEPTION
MVFHCTR (Index) -4.19 8.94 -24.99 -24.99 -- -- -- 4.11
  2018 2019 2020 2021 2022
MVFHCTR (Index) -- -- -- -- -24.99

Discover more ETFs

More ETFs

Past Performance as of 31 Dec 2022

Previous Performance Scenarios

What you will get from this Product depends on future market performance. Market developments in the future are uncertain and cannot be accurately predicted. The monthly unfavourable, moderate, and favourable scenarios shown are illustrations using the worst, average, and best performance of the Product over the last 10 years. Markets could develop very differently in the future.

Recommended holding period: 5 years.
Example Investment: USD 10,000

Showing period:
Referenced Months Minimum There is no minimum guaranteed return.
Stress Unfavourable Moderate Favourable
11/2022 What you might get back after costs (USD) 3,160 5,900 11,360 17,800
Average annual return -68.44% -41.02% 13.56% 77.96%
12/2022 What you might get back after costs (USD) 3,190 5,900 11,300 17,800
Average annual return -68.07% -41.02% 12.97% 77.96%
Referenced Months Minimum There is no minimum guaranteed return.
Stress Unfavourable Moderate Favourable
11/2022 What you might get back after costs (USD) 1,790 1,790 18,870 47,880
Average annual return -29.13% -29.13% 13.54% 36.78%
12/2022 What you might get back after costs (USD) 1,430 1,430 18,880 47,880
Average annual return -32.19% -32.19% 13.55% 36.78%